Computational model to predict response rate of clinical trials von Lorincz, O., Toth, J., Megyesi, M., Pántya, K., Miklos, I., Somogyi, E., Csiszovszki, Z., Pales, P., Molnar, L., Tőke, E.R.

Volltext

1423P - Inferring the correlation between incidence rates of melanoma and the average tumour-specific epitope binding ability of HLA class I molecules in different populations von Miklos, I., Molnar, L., Toth, J., Lorincz, O., Csiszovszki, Z., Pales, P., Pántya, K., Megyesi, M., Somogyi, E., Tőke, E.R.

Volltext

Inferring the correlation between incidence rates of melanoma and the average tumour-specific epitope binding ability of HLA class I molecules in different populations von Miklos, I., Molnar, L., Toth, J., Lorincz, O., Csiszovszki, Z., Pales, P., Pántya, K., Megyesi, M., Somogyi, E., Tőke, E.R.

Volltext

1935P - Computational model to predict response rate of clinical trials von Lorincz, O., Toth, J., Megyesi, M., Pántya, K., Miklos, I., Somogyi, E., Csiszovszki, Z., Pales, P., Molnar, L., Tőke, E.R.

Volltext

Personal antigen selection calculator (PASCal) for the design of personal cancer vaccines von Somogyi, E., Csiszovszki, Z., Lorincz, O., Toth, J., Molnar, L., Schönharting, W., Urban, S., Röhnisch, T., Pántya, K., Pales, P., Megyesi, M., Tőke, E.R.

Volltext

1181PD - Personal antigen selection calculator (PASCal) for the design of personal cancer vaccines von Somogyi, E., Csiszovszki, Z., Lorincz, O., Toth, J., Molnar, L., Schönharting, W., Urban, S., Röhnisch, T., Pántya, K., Pales, P., Megyesi, M., Tőke, E.R.

Volltext

Evaluation of safety, immunogenicity and preliminary efficacy of PolyPEPI1018 vaccine in subjects with metastatic colorectal cancer (mCRC) with a predictive biomarker von Hubbard, J., Cremolini, C., Graham, R.P., Moretto, R., Mitchell, J., Wessling, J., Tőke, E.R., Csiszovszki, Z., Lorincz, O., Molnar, L., Somogyi, E., Megyesi, M., Pántya, K., Toth, J., Pales, P., Miklos, I., Falcone, A.

Volltext

606P - Evaluation of safety, immunogenicity and preliminary efficacy of PolyPEPI1018 vaccine in subjects with metastatic colorectal cancer (mCRC) with a predictive biomarker von Hubbard, J., Cremolini, C., Graham, R.P., Moretto, R., Mitchell, J., Wessling, J., Tőke, E.R., Csiszovszki, Z., Lorincz, O., Molnar, L., Somogyi, E., Megyesi, M., Pántya, K., Toth, J., Pales, P., Miklos, I., Falcone, A.

Volltext

149P Evaluation of HLA genotype as predictive biomarker for immunological and clinical responses upon vaccination with PolyPEPI1018 cancer vaccine against colorectal cancer von Hubbard, J., Molnar, L., Toth, J., Lorincz, O., Csiszovszki, Z., Somogyi, E., Toke, E.R.

Volltext

640P A phase II, multicenter, open-label study of PolyPEPI1018 in combination with atezolizumab in participants with relapsed or refractory microsatellite-stable metastatic colorec... von Hubbard, J., Ahn, D., Jones, J.C., Jin, Z., Zhu, M., Xie, H., Novo, E., Graham, R., Wittenberger, K., Kremlitzka, M., Csiszovszki, Z., Somogyi, E., Lorincz, O., Molnar, L., Toth, J., Youssoufian, H., Toke, E.R.

Volltext

Exploitation of Langerhans cells for in vivo DNA vaccine delivery into the lymph nodes von Tőke, E R, Lőrincz, O, Csiszovszki, Z, Somogyi, E, Felföldi, G, Molnár, L, Szipőcs, R, Kolonics, A, Malissen, B, Lori, F, Trocio, J, Bakare, N, Horkay, F, Romani, N, Tripp, C H, Stoitzner, P, Lisziewicz, J

Volltext